Indian Immunologicals Limited
Overview
Indian Immunologicals Limited (IIL) is a leading biopharmaceutical company based in India, dedicated to developing and manufacturing vaccines and biologicals for both human and animal health. It is one of the largest manufacturers of veterinary vaccines in India and a major player in the human vaccines market.
About Us
Founded in 1982, Indian Immunologicals Limited (IIL) was established to provide affordable vaccines to India, and has since become a major player in disease prevention and control. IIL develops and manufactures a diverse vaccine portfolio, targeting critical animal diseases like rabies, brucellosis, classical swine fever, and foot-and-mouth disease, as well as human diseases such as rabies and Japanese encephalitis. Supported by state-of-the-art manufacturing facilities, IIL is deeply committed to innovation, investing significantly in research and development to enhance its existing products and pioneer new vaccine solutions for evolving healthcare needs. This dedication to both human and animal health highlights IIL's commitment to public health and agricultural sustainability. The company continually seeks to expand its reach and impact through strategic partnerships and collaborations, ensuring access to vital vaccines for communities in need. IIL's core mission remains providing affordable and accessible vaccines to combat critical diseases.
Vision
To be a global leader in providing innovative and affordable healthcare solutions.
Mission
To provide quality and affordable vaccines and biologicals to protect animal and human health.
Headquarters
Hyderabad / Secunderabad
Specialties & Industries
Open Positions
No open positions at the moment
Check back later for new opportunities